BFRA - Biofrontera AG - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $4.67. This is a potential upside of $4.67 (0%) from yesterday's end of day stock price of $0.

Biofrontera AG's activity chart (see below) currently has 12 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.5% with an average time for these price targets to be met of 333.5 days.

Most recent stock forecast was given by BRUCE JACKSON from BENCHMARK on 30-Dec-2021. First documented stock forecast 28-Dec-2018.

Best performing analysts who are covering BFRA - Biofrontera AG:

Bruce Jackson Thomas Flaten

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$6.06 (312.37%)

8

2 years 3 months 20 days ago

3/4 (75%)

$5.41 (79.83%)

381

Buy

11

$9.06 (467.01%)

8

3 years 10 months 29 days ago

7/7 (100%)

$3.92 (55.37%)

286

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BFRA (Biofrontera AG) average time for price targets to be met?

On average it took 333.5 days on average for the stock forecasts to be realized with a an average price target met ratio 87.5

Which analyst has the current highest performing score on BFRA (Biofrontera AG) with a proven track record?

BRUCE JACKSON

Which analyst has the current lower performing score on BFRA (Biofrontera AG) with a proven track record?

THOMAS FLATEN

Which analyst has the most public recommendations on BFRA (Biofrontera AG)?

Bruce Jackson works at BENCHMARK and has 2 price targets and 4 ratings on BFRA

Which analyst is the currently most bullish on BFRA (Biofrontera AG)?

Thomas Flaten with highest potential upside - $9.06

Which analyst is the currently most reserved on BFRA (Biofrontera AG)?

Bruce Jackson with lowest potential downside - $6.06

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?